This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Dr. Daniel Waschke, PhD
Associate Regulatory Program Director at F. Hoffmann-La Roche Ltd.
Speaker

Agenda Sessions

  • Chairperson’s Remarks: Regulatory CMC Strategies for Oligonucleotides

    , 08:00
    View Session

At this event

Prev
Next
Mike Webb, Ph.D.
Founder and CEO
Mike Webb Pharma

See Daniel at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now